Literature DB >> 15837359

Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.

J M Gutiérrez1, E Rojas, L Quesada, G León, J Núñez, G D Laing, M Sasa, J M Renjifo, A Nasidi, D A Warrell, R D G Theakston, G Rojas.   

Abstract

A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa. The antivenom is a whole IgG preparation, obtained by caprylic acid precipitation of non-IgG plasma proteins. The antivenom effectively neutralizes the most important toxic activities of the three venoms used in the immunization in standard assays involving preincubation of venom and antivenom before testing. This antivenom compares favourably with other antivenoms designed for use in Africa with respect to neutralization of the toxins present in the venom of E. ocellatus. Caprylic acid fractionation of horse hyperimmune plasma is a simple, convenient and cheap protocol for the manufacture of high quality whole IgG antivenoms. It constitutes a potentially valuable technology for the alleviation of the critical shortage of antivenom in Africa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837359     DOI: 10.1016/j.trstmh.2004.09.014

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  21 in total

1.  Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Authors:  Juan J Calvete; Pedro Cid; Libia Sanz; Alvaro Segura; Mauren Villalta; María Herrera; Guillermo León; Robert Harrison; Nandul Durfa; Abdusalami Nasidi; R David G Theakston; David A Warrell; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy.

Authors:  Sedigheh Khamehchian; Hossein Zolfagharian; Naser Mohammadpour Dounighi; Majid Tebianian; Rasool Madani
Journal:  Hum Vaccin Immunother       Date:  2014-03-18       Impact factor: 3.452

3.  Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.

Authors:  Isa S Abubakar; Saidu B Abubakar; Abdulrazaq G Habib; Abdulsalam Nasidi; Nandul Durfa; Peter O Yusuf; Solomon Larnyang; John Garnvwa; Elijah Sokomba; Lateef Salako; R David G Theakston; Ed Juszczak; Nicola Alder; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

4.  Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.

Authors:  Nicholas R Casewell; Darren A N Cook; Simon C Wagstaff; Abdulsalami Nasidi; Nandul Durfa; Wolfgang Wüster; Robert A Harrison
Journal:  PLoS Negl Trop Dis       Date:  2010-10-26

5.  A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.

Authors:  José María Gutiérrez; Thierry Burnouf; Robert A Harrison; Juan J Calvete; Ulrich Kuch; David A Warrell; David J Williams
Journal:  Bull World Health Organ       Date:  2014-03-04       Impact factor: 9.408

6.  Confronting the neglected problem of snake bite envenoming: the need for a global partnership.

Authors:  José María Gutiérrez; R David G Theakston; David A Warrell
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

Review 7.  Diagnosis of snakebite and the importance of immunological tests in venom research.

Authors:  R David G Theakston; Gavin D Laing
Journal:  Toxins (Basel)       Date:  2014-05-23       Impact factor: 4.546

Review 8.  Omics meets biology: application to the design and preclinical assessment of antivenoms.

Authors:  Juan J Calvete; Libia Sanz; Davinia Pla; Bruno Lomonte; José María Gutiérrez
Journal:  Toxins (Basel)       Date:  2014-12-15       Impact factor: 4.546

9.  Coral snake antivenom produced in chickens (Gallus domesticus).

Authors:  Irma Aguilar; Elda E Sánchez; María E Girón; Amalid Estrella; Belsy Guerrero; F Alexis Rodriguez-Acosta
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

10.  Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.

Authors:  Felipe Raimondi Guidolin; Celso Pereira Caricati; José Roberto Marcelino; Wilmar Dias da Silva
Journal:  PLoS Negl Trop Dis       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.